Literature DB >> 20122396

WT1 the oncogene: a tale of death and HtrA.

Abdelkader Essafi1, Nicholas D Hastie.   

Abstract

Here, Hartkamp et al. (2010) identify WT1 as a novel bona fide substrate of the HtrA2/Omi mitochondrial protease and show that this reaction modulates WT1 antiapoptotic activity under cytotoxic stress. This supports an oncogenic function for WT1, with implications for novel chemotherapeutic avenues. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122396     DOI: 10.1016/j.molcel.2010.01.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  4 in total

1.  HtrA2, taming the oncogenic activities of WT1.

Authors:  Jörg Hartkamp; Stefan G E Roberts
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 2.  Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.

Authors:  Xiao-wei Qi; Fan Zhang; Hong Wu; Jun-lan Liu; Bei-ge Zong; Chuan Xu; Jun Jiang
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

3.  WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.

Authors:  Bin Zhou; Xianghong Jin; Weiwei Jin; Xingzhou Huang; Yanfei Wu; Haiying Li; Weijian Zhu; Xiaoyi Qin; Haige Ye; Shenmeng Gao
Journal:  J Transl Med       Date:  2020-06-24       Impact factor: 5.531

4.  Prognostic impact of peripheral blood Wilms' tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis.

Authors:  Tomoya Maeda; Akira Matsuda; Chie Asou; Daisuke Okamura; Ken Tanae; Mika Kohri; Maho Ishikawa; Naoki Takahashi; Kunihiro Tsukasaki; Nobutaka Kawai; Norio Asou; Masami Bessho
Journal:  Leuk Res Rep       Date:  2020-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.